Mural Oncology plc (MURA)
Largest Insider Buys in Sector
MURA Stock Price History Chart
MURA Stock Performance
About Mural Oncology plc
Mural Oncology Plc, a clinical-stage oncology company, focuses on discovering and developing immunotherapies for the treatment of patients with cancer. The company's lead product candidate includes nemvaleukin alfa for the treatment of mucosal melanoma as a monotherapy and platinum-resistant ovarian cancer in combination with pembrolizumab. It also develops engineered interleukin-18 and tumor-targeted interleukin-12 programs. The company was incorporated in 2017 and is based in Dublin, Ireland. As of November 15, 2023, Mural Oncology Plc …
Insider Activity of Mural Oncology plc
Over the last 12 months, insiders at Mural Oncology plc have bought $32,071 and sold $95,400 worth of Mural Oncology plc stock.
On average, over the past 5 years, insiders at Mural Oncology plc have bought $32,071 and sold $95,400 worth of stock each year.
Highest buying activity among insiders over the last 12 months: ALTSCHULLER Susan (director) — $32,071.
The last purchase of 10,000 shares for transaction amount of $32,071 was made by ALTSCHULLER Susan (director) on 2024‑08‑14.
List of Insider Buy and Sell Transactions, Mural Oncology plc
| 2024-12-17 | Sale | Chief Executive Officer | 2,763 0.0155% | $3.40 | $9,394 | -6.19% | ||
| 2024-11-07 | Sale | Chief Medical Officer | 5,069 0.0248% | $3.33 | $16,880 | +7.40% | ||
| 2024-10-31 | Sale | Chief Financial Officer | 7,421 0.0372% | $3.41 | $25,306 | 0.00% | ||
| 2024-08-14 | director | 10,000 0.0471% | $3.21 | $32,071 | +7.26% | |||
| 2024-07-18 | Sale | See Remarks | 2,157 0.0108% | $3.41 | $7,355 | -0.88% | ||
| 2024-07-08 | Sale | Chief Executive Officer | 12,531 0.0536% | $2.91 | $36,465 | +11.92% |